Please check your internet connection and try again.
## Ecospirin (Aspirin Enteric-Coated)
### Overview
Ecospirin is an enteric-coated formulation of aspirin, a nonsteroidal anti-inflammatory drug (NSAID) with analgesic, antipyretic, and antiplatelet properties. The enteric coating is designed to delay the dissolution of the tablet until it reaches the small intestine, potentially reducing gastric irritation.
### Primary Indications
* **Cardiovascular Prevention:** Primary and secondary prevention of cardiovascular events (myocardial infarction, stroke) in patients at risk.
* **Pain and Inflammation:** Relief of mild to moderate pain and reduction of fever and inflammation (though other NSAIDs may be preferred for potent anti-inflammatory effects).
### Adult Dosing
* **Cardiovascular Prevention:**
* **Primary Prevention:** Dosing varies based on risk assessment and local guidelines. Commonly, 75 mg to 100 mg once daily is used. Higher doses (e.g., 325 mg) may be used in specific scenarios, but are less common for primary prevention due to increased bleeding risk.
* **Secondary Prevention:** Commonly 75 mg to 100 mg once daily. Doses of 325 mg once daily may be considered in certain acute situations or for patients intolerant to lower doses.
* **Pain, Fever, Inflammation:**
* **Analgesia/Antipyresis:** 325 mg to 650 mg every 4 to 6 hours as needed.
* **Anti-inflammatory:** 2.6 g to 5.4 g per day, divided into 4 to 5 doses. This high-dose regimen is typically reserved for inflammatory conditions like rheumatoid arthritis and requires careful monitoring.
* **Maximum Dose:** For cardiovascular prevention, the typical maximum is 100 mg to 325 mg daily. For pain/fever, the maximum is 4000 mg per day. For inflammatory conditions, the maximum can be up to 5400 mg per day, but this should only be managed by specialists.
### Pediatric Dosing
Aspirin is generally **contraindicated** in children and teenagers with viral infections (e.g., influenza, chickenpox) due to the risk of Reye's syndrome. Specific pediatric dosing for approved indications is not established for this formulation.
### Dose Adjustments
No dose adjustment is typically required for renal or hepatic impairment unless severe. However, caution is advised in these populations due to potential for accumulation and increased risk of adverse effects.
### Contraindications
* Known hypersensitivity to aspirin, salicylates, or NSAIDs.
* Asthma, urticaria, or other allergic-type reactions precipitated by aspirin or other NSAIDs.
* Active peptic ulceration or gastrointestinal bleeding.
* Children and teenagers with viral infections.
* History of bleeding disorders.
### Adverse Effects
* **Gastrointestinal:** Dyspepsia, nausea, vomiting, abdominal pain, heartburn, gastritis, peptic ulceration, gastrointestinal bleeding. Enteric coating may reduce but not eliminate this risk.
* **Hematologic:** Increased bleeding time, bruising, epistaxis.
* **Hypersensitivity:** Bronchospasm, rhinitis, urticaria.
* **Other:** Tinnitus (especially at higher doses), dizziness, headache, Reye's syndrome (in children/teenagers with viral illness).
### Key Drug Interactions
* **Anticoagulants (Warfarin, Heparin, DOACs):** Increased risk of bleeding. Coadministration requires careful monitoring.
* **Other NSAIDs and COX-2 Inhibitors:** Increased risk of gastrointestinal toxicity and bleeding.
* **Corticosteroids:** Increased risk of gastrointestinal ulceration and bleeding.
* **SSRIs and SNRIs:** Increased risk of bleeding.
* **Methotrexate:** Increased methotrexate toxicity.
* **Antihypertensives (ACE inhibitors, ARBs, Beta-blockers):** Aspirin may decrease their efficacy.
* **Uricosuric agents (Probenecid, Sulfinpyrazone):** Aspirin may decrease their uricosuric effect.
* **Alcohol:** Increased risk of gastrointestinal irritation and bleeding.
### Monitoring
* **Signs and symptoms of gastrointestinal bleeding** (e.g., melena, hematemesis, abdominal pain).
* **Signs and symptoms of bleeding** (e.g., bruising, epistaxis, prolonged bleeding from cuts).
* **Renal function** in patients with pre-existing renal disease or those at risk.
* **Hepatic function** in patients with liver disease.
* **Tinnitus** can be an early sign of salicylate toxicity.
### Clinical Pearls
* The enteric coating helps protect the stomach lining but does not completely eliminate the risk of gastrointestinal side effects, especially with long-term use or higher doses.
* Do not crush or chew enteric-coated tablets, as this will destroy the coating and potentially increase gastric irritation.
* In cases of acute ischemic stroke or myocardial infarction, immediate-release aspirin is often preferred for faster absorption and antiplatelet effect.
* The use of aspirin for primary prevention should be individualized based on cardiovascular risk factors and bleeding risk.
***
*Disclaimer: This information is intended for healthcare professionals. Always consult the official prescribing information and relevant guidelines before making any clinical decisions. Dosing may vary based on patient-specific factors and local protocols.*
